Aqueous compositions comprising arbekacin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9511143
APP PUB NO 20140343005A1
SERIAL NO

14344487

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides aqueous liquid pharmaceutical compositions comprising arbekacin and chloride ions. The compositions are well tolerable for use in a method for treatment or prevention of a disease of the upper or lower respiratory tract, wherein the composition is aerosolized and inhaled by the patient. Furthermore, the invention provides arbekacin hydrochloride.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MEIJI SEIKA PHARMA CO., LTD.;PARI PHARMA GMBH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Egle, Roman Munich, DE 2 69
Hahn, Michael Krailling, DE 178 1373
Keller, Manfred Munich, DE 63 1814
Sano, Nao Kanagawa, JP 2 0
Shoji, Kuniko Kanagawa, JP 2 30
Sugano, Toshie Kanagawa, JP 1 0
Tanaka, Masashi Kanagawa, JP 204 2284
Yagi, Yukihiro Kanagawa, JP 12 128

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00